CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Zymeworks Shares Rise Ahead of Key FDA Decision on Zanidatamab

RegulatoryZanidatamabPositive
AI Analysis

Summary

Zymeworks shares are rising ahead of an upcoming FDA decision on zanidatamab. The specific decision date and indication were not disclosed in the article.

Importance:7/10
Sentiment:
0.40
FDAregulatoryzanidatamabdecision pending
Related Companies

Read the original article

Published by yahoo_finance on August 24, 2026 10:48 AM

Read Original